Loading...
Back to narrative

Update shared on09 Oct 2025

Fair value Increased 1.64%
AnalystConsensusTarget's Fair Value
US$225.27
17.5% undervalued intrinsic discount
23 Oct
US$185.95
Loading
1Y
-32.9%
7D
-9.1%

Manhattan Associates’ analyst price target has increased moderately, rising from $227.89 to $231.64. Analysts cite the company’s strong product suite, expanding market position, and robust quarterly results as key drivers for renewed optimism.

Analyst Commentary

Recent analyst coverage of Manhattan Associates reflects an overall positive outlook, with multiple firms initiating new ratings and raising their price targets for the company. Analysts cite strong product innovation and resilient execution as drivers for recent momentum and future growth, while also pointing to a few areas of caution for potential investors.

Bullish Takeaways
  • Bullish analysts highlight Manhattan Associates’ leading position in the warehouse management systems market and note successful expansion into adjacent solutions such as transportation management and supply-chain planning.
  • The company’s cloud-native platform, enhanced by agentic AI initiatives expected later this year, is seen as a catalyst for ongoing market share gains and improved operational efficiency for clients.
  • Analysts note robust cross-selling activity into the existing customer base, contributing to durable revenue growth and improved remaining performance obligations.
  • Strong second-quarter results, driven by disciplined expense management and new customer wins, have fueled optimism for continued upside in the second half of the year and into 2025.
Bearish Takeaways
  • Bearish analysts are cautious about valuation, with some maintaining a hold stance despite improved results. Some prefer to wait for a more attractive entry point or further clarity on market headwinds.
  • Concerns linger around macroeconomic uncertainties and how new go-to-market changes or tariff-related risks could affect execution and future growth trajectories.
  • Some believe current estimates may be achievable, but see a relatively low bar heading into the upcoming earnings cycle. This suggests limited near-term upside.

What's in the News

  • Issued updated earnings guidance for Q3 and Q4, with Q3 targeted total revenue between $270 million and $272 million, and Q4 at a midpoint of $267 million. Full-year 2025 revenue is expected between $1,071 million and $1,075 million, and diluted GAAP EPS between $3.23 and $3.31 (Key Developments)
  • Repurchased 262,341 shares valued at $49.6 million during Q2 2025. This completed the buyback of over 12.69 million shares since 2017, totaling $1.24 billion and representing 19.51% of shares outstanding (Key Developments)

Valuation Changes

  • Consensus Fair Value has risen slightly, increasing from $227.89 to $231.64 per share.
  • Discount Rate edged up marginally from 8.40 percent to 8.44 percent.
  • Revenue Growth forecast increased fractionally, moving from 7.28 percent to 7.31 percent.
  • Net Profit Margin estimate fell slightly from 22.81 percent to 22.76 percent.
  • Future P/E ratio projection is up, rising from 56.5x to 57.6x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.